European Biotech Innovation: $60M Series A Boosting Disruptive Growth
$60m Series A capital to finance and build disruptive European biotech companies,eureKARE who are a pioneering new company focused on financing and building next generation biotechnology companies in the disruptive fields of the microbiome and synthetic biology, today announces its launch…
